FDA Approves Suzetrigine (Journavx) For Acute Pain
Pain management remains a significant challenge in clinical medicine, especially as the opioid crisis underscores the need for safer alternatives. Voltage-gated sodium channels (NaV) play a crucial role in pain signaling, with NaV1.8 being a key contributor in peripheral sensory neurons. Suzetrigine (VX-548), recently FDA-approved as Journavx™, is a highly…








